SCHEMBL7982416

SCHEMBL7982416

CN(CC(=O)O)C(=O)C(=O)C1CNc2cc(F)ccc21

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 3/20 0.32
SLC6A9 P48067 3/20 0.31
ATM Q13315 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7981085 0.85 CA12 (0.34)
SCHEMBL7981155 0.85 NR3C2 (0.33) TACR1
SCHEMBL7992900 0.83 PTGIR (0.33)
SCHEMBL7938183 0.83 ALDH1A1 (0.37) TACR1
SCHEMBL7980536 0.79 PTGDR2 (0.35) SLC6A9
SCHEMBL3906901 0.76 PRKAB2 (0.39)
SCHEMBL7980506 0.75 GAA (0.42)
SCHEMBL7982833 0.75 PKM (0.33)
SCHEMBL7981280 0.73 PIN1 (0.40)
SCHEMBL22864635 0.71 SLC6A3 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009133387-A1 INDOLE- 3 -GLYOXYLAMIDE DERIVATIVES FOR USE AS CALCIUM ION CHANNEL MODULATORS LECTUS THERAPEUTICS LIMITED (GB) 2009-11-05 WO disclosed